Literature DB >> 35243569

Reliability of AMH and AFC measurements and their correlation: a large multicenter study.

Philippe Arvis1, Catherine Rongières2, Olivier Pirrello2, Philippe Lehert3,4.   

Abstract

PURPOSE: Anti-Müllerian hormone (AMH) and antral follicle count (AFC) are correlated with the ovarian response, but their reliability and reproducibility are questionable. This large multicenter study describes their distribution, inter-cycle and inter-center variability, and their correlation.
METHODS: A total of 25,854 IVF cycles among 15,219 patients were selected in 12 ART centers. Statistical distribution of AMH and AFC was studied by using the Kolmogorov-Smirnov test and Shapiro goodness of fit test. The reproducibility of AFC and AMH was measured using a mixed model regressing the logarithmic transformation of AFC with age.
RESULTS: The distribution of AMH and AFC was characterized by a wide dispersion of values, twice more important for AFC, and a logarithmic distribution. The faster decline in AMH than in AFC with age suggests that their correlation changes with age. AMH and AFC showed a very low proportion of concordance in the range of expected poor responders according to Bologna cutoffs. The heterogeneity for AMH and AFC across centers was small, but much larger across patients within each center. Concerning the patients with several successive cycles, the reproducibility for AMH seemed much better than for AFC. Comparing respective performances of AMH and AFC for the prediction of ovarian response depended on the local conditions for measuring these indicators and on the reproducibility of results improved over time.
CONCLUSION: Distribution of AMH and AFC was characterized by the wide dispersion of values, and a logarithmic distribution. Establishing cutoffs or a direct relationship AMH/AFC without considering age seems hazardous. Correlation between AMH and AFC was very poor in the range of poor responders.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  AFC; AMH; Bologna criteria; IVF; Ovarian reserve; Poor ovarian responders

Mesh:

Substances:

Year:  2022        PMID: 35243569      PMCID: PMC9107554          DOI: 10.1007/s10815-022-02449-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  38 in total

1.  Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome.

Authors:  V Gallot; A L Berwanger da Silva; V Genro; M Grynberg; N Frydman; R Fanchin
Journal:  Hum Reprod       Date:  2012-01-24       Impact factor: 6.918

Review 2.  The antral follicle count: practical recommendations for better standardization.

Authors:  Frank J M Broekmans; Dominique de Ziegler; Colin M Howles; Alain Gougeon; Geoffrey Trew; Francois Olivennes
Journal:  Fertil Steril       Date:  2009-07-08       Impact factor: 7.329

3.  Variation in antimüllerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response.

Authors:  Narelle Hadlow; Katherine Longhurst; Allison McClements; Jay Natalwala; Suzanne J Brown; Phillip L Matson
Journal:  Fertil Steril       Date:  2013-02-22       Impact factor: 7.329

4.  Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection: a multicenter multinational analysis including ∼15,000 women.

Authors:  Nikolaos P Polyzos; Panagiotis Drakopoulos; Jose Parra; Antonio Pellicer; Samuel Santos-Ribeiro; Herman Tournaye; Ernesto Bosch; Juan Garcia-Velasco
Journal:  Fertil Steril       Date:  2018-09       Impact factor: 7.329

5.  Prediction of different ovarian responses using anti-Müllerian hormone following a long agonist treatment protocol for IVF.

Authors:  Z Heidar; M Bakhtiyari; M Mirzamoradi; S Zadehmodarres; F S Sarfjoo; M A Mansournia
Journal:  J Endocrinol Invest       Date:  2015-05-17       Impact factor: 4.256

6.  Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts.

Authors:  J van Disseldorp; C B Lambalk; J Kwee; C W N Looman; M J C Eijkemans; B C Fauser; F J Broekmans
Journal:  Hum Reprod       Date:  2009-10-19       Impact factor: 6.918

7.  Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.

Authors:  Didier Dewailly; Marla E Lujan; Enrico Carmina; Marcelle I Cedars; Joop Laven; Robert J Norman; Héctor F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-12-16       Impact factor: 15.610

8.  First fully automated immunoassay for anti-Müllerian hormone.

Authors:  Dieter Gassner; Rebecca Jung
Journal:  Clin Chem Lab Med       Date:  2014-08       Impact factor: 3.694

9.  Predicting the chance of live birth for women undergoing IVF: a novel pretreatment counselling tool.

Authors:  R K Dhillon; D J McLernon; P P Smith; S Fishel; K Dowell; J J Deeks; S Bhattacharya; A Coomarasamy
Journal:  Hum Reprod       Date:  2015-10-25       Impact factor: 6.918

10.  Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.

Authors:  Richard A Anderson; Ellen Anckaert; Ernesto Bosch; Didier Dewailly; Cheryl E Dunlop; Daniel Fehr; Luciano Nardo; Johan Smitz; Kelton Tremellen; Barbara Denk; Andrea Geistanger; Martin Hund
Journal:  Fertil Steril       Date:  2015-02-11       Impact factor: 7.329

View more
  1 in total

1.  Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function.

Authors:  Sudwita Sinha; Amrita Sharan; Sangeeta Sinha
Journal:  Cureus       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.